Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 8/20 | 0.43 |
| ▸ | PYGL | P06737 | 3/20 | 0.43 |
| ▸ | PYGM | P11217 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.36 |
| ▸ | OGA | O60502 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3172797 | 1.00 | PYGB (0.43) | PYGBPYGLPYGMLMNAGBA1 | |
| SCHEMBL12581436 | 1.00 | PYGB (0.43) | PYGBPYGLPYGMLMNAGBA1 | |
| SCHEMBL454317 | 1.00 | PYGB (0.43) | PYGBPYGLPYGMLMNAGBA1 | |
| SCHEMBL3223069 | 1.00 | PYGB (0.43) | PYGBPYGLPYGMLMNAGBA1 | |
| SCHEMBL16812689 | 1.00 | PYGB (0.43) | PYGBPYGLPYGMLMNAGBA1 | |
| SCHEMBL24720641 | 1.00 | PYGB (0.43) | PYGBPYGLPYGMLMNAGBA1 | |
| SCHEMBL3219087 | 1.00 | PYGB (0.43) | PYGBPYGLPYGMLMNAGBA1 | |
| SCHEMBL17354424 | 1.00 | PYGB (0.43) | PYGBPYGLPYGMLMNAGBA1 | |
| SCHEMBL3219097 | 1.00 | PYGB (0.43) | PYGBPYGLPYGMLMNAGBA1 | |
| SCHEMBL12422622 | 1.00 | PYGB (0.43) | PYGBPYGLPYGMLMNAGBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110027803-A1 | Compositions and Methods for Maintenance of Fluid Conducting and Containment Systems | LUX INNOVATE LTD. (GB) | 2011-02-03 | — | — | US | claimed |
| US-20100304418-A1 | Compositions and Methods for Monitoring Flow Through Fluid Conducting and Containment Systems | LUX INNOVATE LTD. (GB) | 2010-12-02 | — | — | US | claimed |
| EP-2235199-A1 | COMPOSITIONS AND METHODS FOR MAINTENANCE OF FLUID CONDUCTING AND CONTAINMENT SYSTEMS | Lux Innovate Limited (GB) | 2010-10-06 | — | — | EP | claimed |
| WO-2009077760-A1 | COMPOSITIONS AND METHODS FOR MAINTENANCE OF FLUID CONDUCTING AND CONTAINMENT SYSTEMS | LUX INNOVATE LIMITED (GB) | 2009-06-25 | — | — | WO | claimed |
| US-20230173012-A1 | USE OF POLYPHENOL CONTAINING SUGAR CANE EXTRACTS FOR PREVENTING, IMPROVING OR TREATING A SKIN CONDITION | THE PRODUCT MAKERS (AUSTRALIA) PTY LTD (AU) | 2023-06-08 | — | — | US | disclosed |
| US-20230157342-A1 | TASTE OF CONSUMABLES | THE PRODUCT MAKERS (AUSTRALIA) PTY LTD (AU) | 2023-05-25 | — | — | US | disclosed |
| US-20200215145-A1 | USE OF POLYPHENOL CONTAINING SUGAR CANE EXTRACTS FOR PREVENTING, IMPROVING OR TREATING A SKIN CONDITION | Poly Gain Pte Ltd (SG) | 2020-07-09 | — | — | US | disclosed |
| US-20200196649-A1 | IMPROVING THE TASTE OF CONSUMABLES | THE PRODUCT MAKERS (AUSTRALIA) PTY LTD (AU) | 2020-06-25 | — | — | US | disclosed |
| EP-3664827-A1 | USE OF POLYPHENOL CONTAINING SUGAR CANE EXTRACTS FOR PREVENTING, IMPROVING OR TREATING A SKIN CONDITION | THE PRODUCT MAKERS (AUSTRALIA) PTY LTD (AU) | 2020-06-17 | — | — | EP | disclosed |
| US-20190167565-A1 | PROBIOTIC TREATMENT OF SKIN DISEASES, DISORDERS, AND INFECTIONS: FORMULATIONS METHODS AND SYSTEMS | BEAUTY BIOLABS, LLC | 2019-06-06 | — | — | US | disclosed |
| US-10238597-B2 | Probiotic treatment of skin diseases, disorders, and infections: formulations, methods and systems | BEAUTY BIOLABS LLC (US) | 2019-03-26 | — | — | US | disclosed |
| WO-2019028506-A1 | USE OF POLYPHENOL CONTAINING SUGAR CANE EXTRACTS FOR PREVENTING, IMPROVING OR TREATING A SKIN CONDITION | THE PRODUCT MAKERS (AUSTRALIA) PTY LTD (AU) | 2019-02-14 | — | — | WO | disclosed |
| US-20170143621-A1 | PROBIOTIC TREATMENT OF SKIN DISEASES, DISORDERS, AND INFECTIONS: FORMULATIONS, METHODS AND SYSTEMS | BEAUTY BIOLABS, LLC | 2017-05-25 | — | — | US | disclosed |
| US-20110027803-A1 | Compositions and Methods for Maintenance of Fluid Conducting and Containment Systems | LUX INNOVATE LTD. (GB) | 2011-02-03 | — | — | US | disclosed |
| US-20100319084-A1 | METABOLIC ENGINEERING FOR PLANT DISEASE RESISTANCE | THE SAMUEL ROBERTS NOBLE FOUNDATION | 2010-12-16 | — | — | US | disclosed |
| US-20100304418-A1 | Compositions and Methods for Monitoring Flow Through Fluid Conducting and Containment Systems | LUX INNOVATE LTD. (GB) | 2010-12-02 | — | — | US | disclosed |
| EP-2235199-A1 | COMPOSITIONS AND METHODS FOR MAINTENANCE OF FLUID CONDUCTING AND CONTAINMENT SYSTEMS | Lux Innovate Limited (GB) | 2010-10-06 | — | — | EP | disclosed |
| EP-2232013-A1 | COMPOSITIONS AND METHODS FOR MONITORING FLOW THROUGH FLUID CONDUCTING AND CONTAINMENT SYSTEMS | Lux Innovate Limited (GB) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009077760-A1 | COMPOSITIONS AND METHODS FOR MAINTENANCE OF FLUID CONDUCTING AND CONTAINMENT SYSTEMS | LUX INNOVATE LIMITED (GB) | 2009-06-25 | — | — | WO | disclosed |
| WO-2009077758-A1 | COMPOSITIONS AND METHODS FOR MONITORING FLOW THROUGH FLUID CONDUCTING AND CONTAINMENT SYSTEMS | LUX INNOVATE LIMITED (GB) | 2009-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10238597-B2 | Probiotic treatment of skin diseases, disorders, and infections: formulations, methods and systems | CUTA, IL17A, TSLP | PYGB 3693/4885PYGL 3628/4885PYGM 2749/4885 |
| US-20190167565-A1 | PROBIOTIC TREATMENT OF SKIN DISEASES, DISORDERS, AND INFECTIONS: FORMULATIONS METHODS AND SYSTEMS | CUTA, IL17A, MMP11 | PYGB 3697/4885PYGL 3639/4885PYGM 2639/4885 |
| US-20170143621-A1 | PROBIOTIC TREATMENT OF SKIN DISEASES, DISORDERS, AND INFECTIONS: FORMULATIONS, METHODS AND SYSTEMS | CUTA, IL17A, TSLP | PYGB 3693/4885PYGL 3628/4885PYGM 2749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.